Psychiatric characterization of donors and recipicients of living donor liver transplantation - a prospective study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003607

Enrollment

Registered

2012-03-15

Start date

2012-03-12

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with terminal liver dysfunction leading to necessity of transplantation Z94.4 K72.9

Interventions

Group 1: single arm study. Each donors and recipicients of living donor liver transplantation will be asekd by psychometric self rating questionnaires at four time points: Baseline (before transplanta

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: patients with terminal liver insufficiency which makes a liver transplantaion necessary

Exclusion criteria

Exclusion criteria: cognitive deficits that prevent from understanding the psychometric tests.

Design outcomes

Primary

Measure	Time frame
Primary end point of the study is the change of psychometric variables in terms of depression, anxiety and traumatic symptoms and life quality compared to the parameters in the baseline assessment. This will be measured in 3 follow up points: 3. month after transplantation: rating of depressive (BDI), posttraumatic (PTSS-10), anxiety (STAI) symptoms and general life quality (FLZ, SCL-90R). 6. month after transplantation: rating of depressive (BDI), posttraumatic (PTSS-10), anxiety (STAI) symptoms and general life quality (FLZ, SCL-90R). 12. month after transplantation: rating of depressive (BDI), posttraumatic (PTSS-10), anxiety (STAI) symptoms and general life quality (FLZ, SCL-90R).	—

Measure

Time frame

Primary end point of the study is the change of psychometric variables in terms of depression, anxiety and traumatic symptoms and life quality compared to the parameters in the baseline assessment. This will be measured in 3 follow up points: 3. month after transplantation: rating of depressive (BDI), posttraumatic (PTSS-10), anxiety (STAI) symptoms and general life quality (FLZ, SCL-90R). 6. month after transplantation: rating of depressive (BDI), posttraumatic (PTSS-10), anxiety (STAI) symptoms and general life quality (FLZ, SCL-90R). 12. month after transplantation: rating of depressive (BDI), posttraumatic (PTSS-10), anxiety (STAI) symptoms and general life quality (FLZ, SCL-90R).

—

Secondary

Measure	Time frame
not applicable.	—

Countries

Germany

Contacts

Public ContactUlrich Palm

Klinik für Psychiatrie, Psychotherapie und Psychosomatik

ulrich.palm@med.uni-muenchen.de089/5160-5511

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026